Retinoids are known to repress Otx2 during anterior-posterior embryonic patterning [18] and when added to cultured medulloblastoma cells [19], [20], and thus have been considered a potential therapeutic agent for medulloblastoma. The gene discussed is OTX2; the disease is medulloblastoma.